Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Treatment
What Are Rapidly Progressive Dementias?
As Mouse Studies Fall Short in Alzheimer’s Research, Scientists Turn to Monkeys
Living With Parkinson’s and Dementia: A LiveTalk With John Gastil and Dr. Zoltan Mari
Does Eli Lilly’s Alzheimer’s Drug Donanemab Work? Key New Data Released
Could Mitochondria in Our Blood Help Treat Alzheimer’s?
Repairing the Brain With Stem Cells? A BrainTalk With Jack Price
In Place of a Miracle Drug, Attacking Alzheimer’s With Infrared Lasers?
Why Is Alzheimer’s Research So White?
This Discovery May Speed Up Alzheimer’s Drug Testing
What If You Could Get the Brain-Boosting Benefits of Six Weeks of Exercise in a Pill?
Biogen Seeks FDA Approval for Alzheimer’s Drug Aducanumab
The First One-Patient Stem Cell Experiment for Parkinson’s
Cancer Drug Nilotinib Shows Promise for Treatment of Alzheimer’s
Shedding Light on an Entirely New Approach to Curing Alzheimer’s
Seaweed Alzheimer’s Drug Approved for U.S. Clinical Trials — First New Drug in 17 years
Previous
3
4
5
Next
Page load link
Go to Top